212 related articles for article (PubMed ID: 31124321)
41. [EURAP: the European Registry of Antiepileptic Drugs and Pregnancy].
Kretz R; Coban I; Gaus V; Schmitz B
Nervenarzt; 2006 Jun; 77(6):722, 724-8. PubMed ID: 16614866
[TBL] [Abstract][Full Text] [Related]
42. Women with drug-resistant epilepsy: Surgery or pregnancy first?
Kandraju SS; Jose M; Salini RA; Pavithran V; Samuel Peedicail J; Menon RN; Radhakrishnan A; Cherian A; Abraham M; Vilanilam GC; Thomas SV
Epilepsia; 2020 Aug; 61(8):1758-1763. PubMed ID: 32706922
[TBL] [Abstract][Full Text] [Related]
43. [Malformations in the offspring of pregnant women with epilepsy. Presentation of an international registry of antiepileptic drugs and pregnancy (EURAP)].
Battino D; Mamoli D; Messina S; Perucca E; Tomson T
Rev Neurol; 2002 Mar 1-15; 34(5):476-80. PubMed ID: 12040519
[TBL] [Abstract][Full Text] [Related]
44. Pregnancy registries: differences, similarities, and possible harmonization.
Tomson T; Battino D; Craig J; Hernandez-Diaz S; Holmes LB; Lindhout D; Morrow J; French J;
Epilepsia; 2010 May; 51(5):909-15. PubMed ID: 20196792
[TBL] [Abstract][Full Text] [Related]
45. Levetiracetam Use During Pregnancy in Women With Active Epilepsy: A Hospital-Based, Retrospective Study from a Tertiary Care Hospital in North Eastern INDIA.
Sharma SR; Sharma N; Hussain M; Mobing H; Hynniewta Y
Neurol India; 2021; 69(3):692-697. PubMed ID: 34169870
[TBL] [Abstract][Full Text] [Related]
46. EURAP: an international registry of antiepileptic drugs and pregnancy.
Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Vajda F;
Epilepsia; 2004 Nov; 45(11):1463-4. PubMed ID: 15509250
[No Abstract] [Full Text] [Related]
47. Newer-generation antiepileptic drugs and the risk of major birth defects.
Mølgaard-Nielsen D; Hviid A
JAMA; 2011 May; 305(19):1996-2002. PubMed ID: 21586715
[TBL] [Abstract][Full Text] [Related]
48. Fetal loss and malformations in the MONEAD study of pregnant women with epilepsy.
Meador KJ; Pennell PB; May RC; Van Marter L; McElrath TF; Brown C; Gerard E; Kalayjian L; Gedzelman E; Penovich P; Cavitt J; French J; Hwang S; Pack AM; Sam M; Birnbaum AK; Finnell R;
Neurology; 2020 Apr; 94(14):e1502-e1511. PubMed ID: 31806691
[TBL] [Abstract][Full Text] [Related]
49. Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register.
Hunt S; Russell A; Smithson WH; Parsons L; Robertson I; Waddell R; Irwin B; Morrison PJ; Morrow J; Craig J;
Neurology; 2008 Jul; 71(4):272-6. PubMed ID: 18645165
[TBL] [Abstract][Full Text] [Related]
50. Epilepsy, pregnancy, and major birth anomalies: an Italian prospective, controlled study.
Tanganelli P; Regesta G
Neurology; 1992 Apr; 42(4 Suppl 5):89-93. PubMed ID: 1574184
[TBL] [Abstract][Full Text] [Related]
51. The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months.
Vajda FJ; O'Brien TJ; Hitchcock A; Graham J; Lander C
J Clin Neurosci; 2003 Sep; 10(5):543-9. PubMed ID: 12948456
[TBL] [Abstract][Full Text] [Related]
52. Comparative Risk of Major Congenital Malformations With 8 Different Antiepileptic Drugs: A Prospective Cohort Study of the EURAP Registry.
Vossler DG
Epilepsy Curr; 2019; 19(2):83-85. PubMed ID: 30955418
[TBL] [Abstract][Full Text] [Related]
53. Antiepileptic drug combinations not involving valproate and the risk of fetal malformations.
Vajda FJ; O'Brien TJ; Lander CM; Graham J; Eadie MJ
Epilepsia; 2016 Jul; 57(7):1048-52. PubMed ID: 27265509
[TBL] [Abstract][Full Text] [Related]
54. Valproic acid monotherapy in pregnancy and major congenital malformations.
Jentink J; Loane MA; Dolk H; Barisic I; Garne E; Morris JK; de Jong-van den Berg LT;
N Engl J Med; 2010 Jun; 362(23):2185-93. PubMed ID: 20558369
[TBL] [Abstract][Full Text] [Related]
55. Levetiracetam use in pregnancy.
Longo B; Forinash AB; Murphy JA
Ann Pharmacother; 2009 Oct; 43(10):1692-5. PubMed ID: 19690219
[TBL] [Abstract][Full Text] [Related]
56. Comparative safety of antiepileptic drugs during pregnancy.
Hernández-Díaz S; Smith CR; Shen A; Mittendorf R; Hauser WA; Yerby M; Holmes LB; ;
Neurology; 2012 May; 78(21):1692-9. PubMed ID: 22551726
[TBL] [Abstract][Full Text] [Related]
57. Levetiracetam monotherapy during pregnancy: a case series.
Long L
Epilepsy Behav; 2003 Aug; 4(4):447-8. PubMed ID: 12899868
[TBL] [Abstract][Full Text] [Related]
58. Pregabalin use early in pregnancy and the risk of major congenital malformations.
Patorno E; Bateman BT; Huybrechts KF; MacDonald SC; Cohen JM; Desai RJ; Panchaud A; Mogun H; Pennell PB; Hernandez-Diaz S
Neurology; 2017 May; 88(21):2020-2025. PubMed ID: 28446648
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up study.
Friend S; Richman S; Bloomgren G; Cristiano LM; Wenten M
BMC Neurol; 2016 Aug; 16(1):150. PubMed ID: 27552976
[TBL] [Abstract][Full Text] [Related]
60. Epidemiology of major congenital malformations with specific focus on teratogens.
Chaabane S; Bérard A
Curr Drug Saf; 2013 Apr; 8(2):128-40. PubMed ID: 23656452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
